GSK plc ADR buy StockNews.com
Start price
28.12.24
/
50%
€32.60
Target price
28.12.25
-
Performance (%)
26.99%
End price
29.12.25
€41.40
Summary
This prediction ended on 29.12.25 with a price of €41.40. The prediction had a final performance of 26.99%. StockNews_com has a follow-up prediction for GSK plc ADR where he still thinks GSK plc ADR is a Buy. Dividends of €0.38 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 2.110% | 2.110% | 34.444% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by StockNews_com for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten